University of Maryland Greenebaum Cancer Center 22 S. Greene Street

22 South Greene Street
Baltimore, Maryland 21201

We've found

1 trials

at this facility

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Status: Enrolling, Phase II
Updated: 2/7/2018

from

Baltimore, MD

Use our guide to learn which trials are right for you!